Saturday 17 October 2026
Export XTNT’s income statement to Excel — free account
Xtant Medical Holdings, Inc.
XTNT Healthcare Medical Devices
Xtant Medical Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $133.9 million, up 14.2% from fiscal 2024. In the quarter to June 2026, revenue fell 35.0%, EPS fell 333.3%, free cash flow fell 882.0% and total debt fell 33.0%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
0.28
0.02
−6.67%
Follow XTNT
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
19.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
8 | 2 | 4 | 2 | 4 | 3 | 5 | 5 | 2 | 3 |
P/S ratio |
0.81 | 0.50 | 1.58 | 1.09 | 0.87 | 0.64 | 0.33 | 0.26 | 0.12 | 0.08 |
Altman Z-Score |
0.03 | (1.86) | (0.55) | (2.96) | (3.31) | (5.62) | (5.14) | (8.49) | (2.12) | (0.27) |
P/FCF ratio |
10.47 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 22.37 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(3.66) | (6.30) | (5.02) | (8.85) | (9.14) | (16.76) | (14.27) | (21.11) | (6.39) | (1.68) |
Beneish M-Score |
(3.11) | (2.77) | (0.79) | (2.26) | (2.79) | (3.26) | (3.15) | (10.27) | (5.23) | (2.45) |
P/Operating CF |
20.23 | 88.44 | (157.49) | (27.55) | 113.13 | 37.34 | (296.65) | 9.49 | 15.97 | (2.21) |
P/B ratio |
2.14 | 1.37 | 2.81 | 1.84 | 1.55 | 2.36 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
2.44 | 2.15 | 4.24 | 2.06 | 1.75 | 3.15 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.87 | 0.74 | 1.75 | 1.00 | 0.81 | 0.94 | 1.43 | 2.16 | 2.56 | 1.50 |
EV/EBITDA |
9.35 | 0.00 | 0.00 | 0.00 | 0.00 | 37.62 | 104.09 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
9.32 | (7.30) | (16.82) | (10.88) | 102.46 | (68.34) | (224.31) | 128.60 | (389.79) | (9.37) |
EV/FCF |
11.24 | (5.55) | (14.83) | (8.42) | (31.00) | (24.55) | (96.80) | 184.45 | (98.40) | (6.68) |
Quick Ratio |
1.19 | 0.94 | 1.16 | 2.06 | 2.31 | 0.36 | 1.64 | 1.39 | 0.60 | 0.69 |
Current Ratio |
2.65 | 2.35 | 2.82 | 3.24 | 4.00 | 1.22 | 3.43 | 2.88 | 1.54 | 1.57 |
Net Debt/EBITDA |
0.65 | (3.56) | (2.29) | 0.90 | 1.14 | 11.87 | 80.42 | (1.34) | (4.63) | (421.63) |
Debt/Assets |
26.97% | 36.45% | 23.65% | 25.87% | 28.36% | 43.65% | 178.00% | 169.25% | 131.45% | 90.56% |
Debt/Equity |
0.50 | 0.80 | 0.43 | 0.46 | 0.50 | 1.25 | (1.74) | (1.79) | (2.37) | (18.45) |
Asset Turnover |
1.42 | 1.26 | 1.19 | 1.01 | 1.15 | 1.26 | 1.44 | 0.95 | 0.66 | 0.63 |
Operating CF/Net income |
2.52 | 0.72 | (14.42) | 0.63 | (0.09) | 0.10 | 0.05 | (0.02) | 0.01 | 0.74 |
Capex/Depreciation |
(0.41) | (0.88) | (0.40) | (1.21) | (1.42) | (0.63) | (0.17) | (0.06) | (0.19) | (0.80) |
Interest Coverage |
1.98 | (2.90) | (3.46) | (3.99) | (3.87) | (0.13) | (0.39) | (5.92) | (2.57) | (0.62) |
| 10.59% | (34.88%) | 1.54% | (26.09%) | (21.36%) | 47.31% | 18.69% | 136.82% | 159.37% | (2,162.11%) | |
| 5.29% | (17.64%) | 0.86% | (14.77%) | (10.09%) | (16.60%) | (18.36%) | (92.16%) | (41.96%) | (13.67%) | |
ROIC |
7.71% | (10.64%) | (9.43%) | (14.44%) | (8.60%) | (1.55%) | (5.14%) | (134.10%) | (30.55%) | (3.90%) |
Return on Tangible Assets |
9.05% | (33.80%) | 1.31% | (21.27%) | (12.61%) | (69.79%) | (29.84%) | (235.23%) | (220.27%) | (57.83%) |
Average Days of Receivables |
48.52 | 64.31 | 82.88 | 68.34 | 47.25 | 47.08 | 57.13 | 50.50 | 56.17 | 77.02 |
Research and Development Expense of Revenue |
1.57% | 2.03% | 1.46% | 1.58% | 1.57% | 1.23% | 1.44% | 2.36% | 2.95% | 3.79% |
Selling, General and Administrative Expense of Revenue |
55.92% | 66.43% | 70.41% | 65.51% | 64.19% | 64.66% | 67.77% | 63.35% | 67.60% | 66.76% |
Intangible Assets out of Total Assets |
0.07 | 0.17 | 0.19 | 0.06 | 0.07 | 0.09 | 0.09 | 0.08 | 0.52 | 0.54 |
Share Based Compensation of Revenue |
2.16% | 3.51% | 3.00% | 4.25% | 4.00% | 2.03% | 0.80% | 0.96% | 0.00% | 0.00% |
Graham Net Nets |
0.32 | 0.28 | 0.16 | 0.37 | 0.43 | 0.13 | (2.62) | (2.94) | (12.09) | (14.40) |
Graham Number |
0.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.84 | 21.73 | 173.67 | 37.56 |
Earnings Yield |
5.23% | (27.27%) | 0.00% | (14.93%) | (10.79%) | (40.83%) | (38.75%) | (349.69%) | (503.48%) | (139.32%) |
Free Cash Flow Yield |
9.55% | (26.57%) | (7.49%) | (10.95%) | (3.03%) | (5.95%) | (4.54%) | 4.47% | (20.85%) | (284.99%) |
Revenue per Share |
0.96 | 0.88 | 0.77 | 0.62 | 0.65 | 1.87 | 4.91 | 6.15 | 54.78 | 85.23 |
Operating CF per Share |
0.09 | (0.09) | (0.08) | (0.06) | 0.01 | (0.03) | (0.03) | 0.10 | (0.36) | (13.64) |
Capex per Share |
(0.02) | (0.03) | (0.01) | (0.02) | (0.02) | (0.05) | (0.04) | (0.03) | (1.07) | (5.51) |
Free Cash Flow per Share |
0.07 | (0.12) | (0.09) | (0.07) | (0.02) | (0.07) | (0.07) | 0.07 | (1.43) | (19.15) |
Cash per Share |
0.12 | 0.05 | 0.05 | 0.22 | 0.22 | 0.08 | 0.40 | 0.58 | 1.89 | 2.44 |
Shareholders Equity per Share |
0.37 | 0.32 | 0.43 | 0.36 | 0.36 | 0.51 | (3.36) | (3.73) | (38.93) | (6.70) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.37 | 0.32 | 0.43 | 0.36 | 0.36 | 0.51 | (3.36) | (3.73) | (38.93) | (6.70) |
Free Cash Flow |
10.40 | (15.63) | (10.80) | (6.90) | (1.45) | (2.03) | (0.96) | 0.85 | (2.15) | (20.22) |
Working Capital |
48.76 | 38.54 | 41.88 | 34.10 | 33.25 | 5.72 | 22.86 | 22.63 | 13.88 | 17.86 |
Capital Expenditures |
(2.15) | (3.73) | (1.28) | (1.56) | (1.89) | (1.30) | (0.54) | (0.37) | (1.61) | (5.82) |
Net Current Asset Value |
35.05 | 16.24 | 23.61 | 23.26 | 20.52 | 4.41 | (55.11) | (55.52) | (124.70) | (102.19) |
EV/EBIT |
16.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.02 | 0.03 | 0.01 | 0.03 | 0.03 | 0.02 | 0.01 | 0.01 | 0.02 | 0.06 |
Price to Operating Income |
14.94 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.84 | 0.42 | 0.37 | 0.22 | 0.26 | 0.48 | 0.67 | 0.92 | 0.85 | 0.46 |
Cash ROIC |
11.10% | (18.74%) | (13.64%) | (9.82%) | (2.24%) | (5.82%) | (2.53%) | 2.03% | (2.59%) | (16.05%) |
Accounts Receivable Turnover |
6.96 | 5.67 | 5.78 | 6.44 | 7.88 | 6.27 | 6.43 | 6.36 | 5.21 | 5.24 |
Accounts Payable Turnover |
8.44 | 6.55 | 6.80 | 8.46 | 8.19 | 7.38 | 5.12 | 3.60 | 3.16 | 2.53 |
Inventory Turnover |
1.44 | 1.30 | 1.32 | 1.47 | 1.16 | 1.01 | 1.33 | 1.45 | 1.34 | 1.13 |
Average Days of Payables |
28.26 | 58.92 | 71.85 | 49.31 | 41.91 | 56.78 | 36.03 | 82.17 | 106.39 | 146.37 |
Days of Inventory on Hand |
222.46 | 287.48 | 375.68 | 244.23 | 287.62 | 412.45 | 265.13 | 219.90 | 251.74 | 345.99 |
Average Receivables |
19.23 | 20.70 | 15.79 | 9.00 | 7.02 | 8.50 | 10.06 | 11.35 | 15.85 | 17.19 |
Average Payables |
5.88 | 7.49 | 5.27 | 3.05 | 2.78 | 2.57 | 4.33 | 7.97 | 10.29 | 10.95 |
Average Inventory |
34.45 | 37.76 | 27.09 | 17.62 | 19.68 | 18.75 | 16.70 | 19.86 | 24.34 | 24.48 |
Average Assets |
93.99 | 93.22 | 76.42 | 57.46 | 48.08 | 42.31 | 44.79 | 76.06 | 124.90 | 142.56 |
Average Common Equity |
46.96 | 47.16 | 42.76 | 32.53 | 22.70 | (14.85) | (43.99) | (51.24) | (32.89) | 0.90 |
Columns are period end dates